Biomarkers of progestin therapy resistance and endometrial hyperplasia progression

OBJECTIVE: To identify biomarkers associated with progestin therapy resistance and persistence/progression of endometrial hyperplasia. STUDY DESIGN: We performed a nested case-control study among women with complex (n=73) and atypical (n=41) hyperplasia treated with oral progestin, followed 2–6 mont...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Upson, Kristen, Allison, Kimberly H., Reed, Susan D., Jordan, Carolyn D., Newton, Katherine M., Swisher, Elizabeth M., Doherty, Jennifer A., Garcia, Rochelle L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3398620/
https://ncbi.nlm.nih.gov/pubmed/22727345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2012.05.012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak